IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Orchid Eyes European Purchase

10:54 AM MDT | July 27, 2007 | Chemical Week Editorial Staff

Pharma company Orchid Chemicals & Laboratories (Chennai, India) says it intends to make an acquisition in Europe as part of a strategy to gain access to the high-value international generic injectable drugs market. Orchid says it may issue shares to pay for the planned acquisition, depending on the size of the company that it buys. Orchid says it has yet to identify an acquisition target, but that it is looking for a “front-end” company with a sales force as well as divisions for quality control and post-marketing...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa